Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders??? Equity

v3.19.3
Condensed Consolidated Statements of Stockholders’ Equity - USD ($)
$ in Thousands
Total
March 2019
Lincoln Park
April Offerings
June 2018
Licence Rights
Common Stock
Common Stock
March 2019
Common Stock
Lincoln Park
Common Stock
April Offerings
Common Stock
June 2018
Common Stock
Licence Rights
Additional Paid-In Capital
Additional Paid-In Capital
March 2019
Additional Paid-In Capital
Lincoln Park
Additional Paid-In Capital
April Offerings
Additional Paid-In Capital
June 2018
Additional Paid-In Capital
Licence Rights
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Beginning Balance at Dec. 31, 2017 $ 17,118           $ 21           $ 31,577           $ (14,480)  
Beginning Balance (in shares) at Dec. 31, 2017             21,469,109                          
Increase (Decrease) in Stockholders' Equity                                        
Issued for cash - sale of common stock 5,122           $ 5           5,117              
Issued for cash - sale of common stock (in shares)             4,290,000                          
Stock-based compensation 242                       242              
Consolidated net loss (1,927)                                   (1,927)  
Warrants exercised 15                       15              
Warrants exercised (in shares)             9,752                          
Ending Balances at Mar. 31, 2018 20,570           $ 26           36,951           (16,407) $ 0
Ending Balances (in shares) at Mar. 31, 2018             25,768,861                          
Beginning Balance at Dec. 31, 2017 17,118           $ 21           31,577           (14,480)  
Beginning Balance (in shares) at Dec. 31, 2017             21,469,109                          
Increase (Decrease) in Stockholders' Equity                                        
Consolidated net loss (9,091)                                      
Ending Balances at Sep. 30, 2018 14,969           $ 27           38,491           (23,570) 21
Ending Balances (in shares) at Sep. 30, 2018             26,861,497                          
Beginning Balance at Mar. 31, 2018 20,570           $ 26           36,951           (16,407) 0
Beginning Balance (in shares) at Mar. 31, 2018             25,768,861                          
Increase (Decrease) in Stockholders' Equity                                        
Issued for cash - sale of common stock         $ 958           $ 1           $ 957      
Issued for cash - sale of common stock (in shares)                     1,092,636                  
Stock-based compensation 339                       339              
Consolidated net loss (5,125)                                   (5,125)  
Cumulative translation adjustment 6                                     6
Ending Balances at Jun. 30, 2018 16,748           $ 27           38,247           (21,532) 6
Ending Balances (in shares) at Jun. 30, 2018             26,861,497                          
Increase (Decrease) in Stockholders' Equity                                        
Stock-based compensation 244                       244              
Consolidated net loss (2,038)                                   (2,038)  
Cumulative translation adjustment 15                                     15
Ending Balances at Sep. 30, 2018 14,969           $ 27           38,491           (23,570) 21
Ending Balances (in shares) at Sep. 30, 2018             26,861,497                          
Increase (Decrease) in Stockholders' Equity                                        
Issued for cash - sale of common stock (in shares)     1,399,153                                  
Ending Balances at Dec. 31, 2018 14,272           $ 29           40,564           (26,356) 35
Ending Balances (in shares) at Dec. 31, 2018             28,528,663                          
Increase (Decrease) in Stockholders' Equity                                        
Issued for cash - sale of common stock   $ 3,226 $ 883         $ 5           $ 3,221 $ 883          
Issued for cash - sale of common stock (in shares)     605,367         5,250,000 605,367                      
Stock options exercised 5                       5              
Stock options exercised (in shares)             25,000                          
Stock-based compensation 348                       348              
Consolidated net loss (4,041)                                   (4,041)  
Cumulative translation adjustment (11)                                     (11)
Ending Balances at Mar. 31, 2019 14,682           $ 34           45,021           (30,397) 24
Ending Balances (in shares) at Mar. 31, 2019             34,409,030                          
Beginning Balance at Dec. 31, 2018 $ 14,272           $ 29           40,564           (26,356) 35
Beginning Balance (in shares) at Dec. 31, 2018             28,528,663                          
Increase (Decrease) in Stockholders' Equity                                        
Stock options exercised (in shares) 25,000                                      
Consolidated net loss $ (9,408)                                      
Ending Balances at Sep. 30, 2019 18,975           $ 46           54,673           (35,763) 19
Ending Balances (in shares) at Sep. 30, 2019             45,727,700                          
Beginning Balance at Mar. 31, 2019 14,682           $ 34           45,021           (30,397) 24
Beginning Balance (in shares) at Mar. 31, 2019             34,409,030                          
Increase (Decrease) in Stockholders' Equity                                        
Issued for cash - sale of common stock       $ 3,584           $ 9           $ 3,575        
Issued for cash - sale of common stock (in shares)     0             9,375,000                    
Stock-based compensation 318                       318              
Consolidated net loss (1,221)                                   (1,221)  
Cumulative translation adjustment (2)                                     (2)
Warrants exercised 4,731           $ 2           4,729              
Warrants exercised (in shares)             1,413,018                          
Ending Balances at Jun. 30, 2019 22,092           $ 45           53,643           (31,618) 22
Ending Balances (in shares) at Jun. 30, 2019             45,197,048                          
Increase (Decrease) in Stockholders' Equity                                        
Issued for cash - sale of common stock     $ 52     $ 490           $ 1     $ 52     $ 489    
Issued for cash - sale of common stock (in shares)     100,674           100,674     429,978                
Stock-based compensation 489                       489              
Consolidated net loss (4,145)                                   (4,145)  
Cumulative translation adjustment (3)                                     (3)
Ending Balances at Sep. 30, 2019 $ 18,975           $ 46           $ 54,673           $ (35,763) $ 19
Ending Balances (in shares) at Sep. 30, 2019             45,727,700